Clinical outcome and immune reconstitution following alemtuzumab T cell depleted nonmyeloablative allogeneic immunotherapy using HLA mis-matched (3-5/6) related hematopoietic stem cells.
Conference Paper
Full Text
Duke Authors
Cited Authors
- Rizzieri, DA; Koh, LP; Long, GD; Gasparetto, C; Vredenburgh, JJ; Buckley, PJ; Gong, G; Lagoo, A; Davis, P; Lassiter, M; Rooney, B; Niedzwiecki, D; Waters-Pick, B; Burleson, J; Thompson, M; Johns, A; Folz, RJ; Horwtiz, ME; Sullivan, K; Morris, A; Chao, NJ
Published Date
- November 16, 2003
Published In
Volume / Issue
- 102 / 11
Start / End Page
- 482A - 482A
Published By
Pages
- 1
International Standard Serial Number (ISSN)
- 0006-4971
Conference Name
- 45th Annual Meeting of the American-Society-of-Hematology
Conference Location
- SAN DIEGO, CALIFORNIA
Conference Start Date
- December 6, 2003
Conference End Date
- December 9, 2003